PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 215 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q4 2020. The put-call ratio across all filers is 1.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $601,000 | -42.4% | 72,097 | -8.0% | 0.00% | -50.0% |
Q2 2023 | $1,043,000 | +0.1% | 78,341 | -12.9% | 0.00% | 0.0% |
Q1 2023 | $1,042,000 | +47.2% | 89,906 | +3.7% | 0.00% | 0.0% |
Q4 2022 | $708,000 | +12.4% | 86,723 | -19.8% | 0.00% | 0.0% |
Q3 2022 | $630,000 | -10.4% | 108,138 | -32.6% | 0.00% | 0.0% |
Q2 2022 | $703,000 | -63.0% | 160,423 | -23.1% | 0.00% | -50.0% |
Q1 2022 | $1,902,000 | +2.1% | 208,665 | +129.6% | 0.00% | 0.0% |
Q4 2021 | $1,862,000 | -10.3% | 90,885 | +11.9% | 0.00% | -33.3% |
Q3 2021 | $2,076,000 | -28.0% | 81,239 | -1.6% | 0.01% | -25.0% |
Q2 2021 | $2,885,000 | -7.5% | 82,560 | -11.1% | 0.01% | -20.0% |
Q1 2021 | $3,119,000 | +740.7% | 92,833 | +549.2% | 0.01% | +400.0% |
Q4 2020 | $371,000 | +267.3% | 14,300 | -48.5% | 0.00% | +100.0% |
Q2 2017 | $101,000 | +7.4% | 27,785 | +35.1% | 0.00% | 0.0% |
Q1 2017 | $94,000 | – | 20,560 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ORACLE INVESTMENT MANAGEMENT INC | 1,446,459 | $48,182,000 | 7.22% |
BOURNE LENT ASSET MANAGEMENT INC | 536,800 | $17,881,000 | 5.70% |
Casdin Capital, LLC | 5,000,000 | $166,550,000 | 4.96% |
Iron Triangle Partners LP | 935,805 | $31,172,000 | 3.96% |
Jackson Square Partners, LLC | 12,911,695 | $430,088,000 | 2.44% |
SB Management Ltd | 9,861,089 | $328,473,000 | 2.12% |
Abacus Planning Group, Inc. | 180,000 | $5,996,000 | 1.92% |
BERKSHIRE CAPITAL HOLDINGS INC | 413,800 | $13,784,000 | 1.57% |
ARK Investment Management | 21,301,191 | $709,543,000 | 1.41% |
Nikko Asset Management Americas, Inc. | 5,247,237 | $174,785,000 | 0.86% |